Leukaemia Trial, Recruiting (NCT06250465)

Leukaemia Trial, Recruiting NCT06250465 Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie Condition: Leukaemia

Printed from Voxsanity (voxsanity.com.au) — NCT06250465 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Leukaemia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 years or older who have been diagnosed with chronic lymphocytic leukaemia (CLL), a type of blood and bone marrow cancer.

Who may not be able to join:

There are no specific exclusion criteria listed for this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Richard Greil, MD, Department of internal Medicine III, Paracelsus Medical University Salzburg, Austria

Phone: +43 662 640 44 12

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06250465

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie

Phase: Not Applicable

Status: Recruiting

Condition: Leukaemia

Trial contact: +43 662 640 44 12

More information: https://clinicaltrials.gov/study/NCT06250465

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 years or older who have been diagnosed with chronic lymphocytic leukaemia (CLL), a type of blood and bone marrow cancer.

Who may not be able to join:

There are no specific exclusion criteria listed for this trial.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Arbeitsgemeinschaft medikamentoese Tumortherapie

Registry

ClinicalTrials.gov

Start date

24 March 2022

Est. completion

31 December 2027

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

General Characteristics; Genetic Profiling; Proportion of CLL patients in Austria that require treatment; Number of patients with concomitant diseases; Number and type of treatment; Patient Outcome; Toxicities

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov